Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer.

ABSTRACT:

Background

The purpose of this study is to describe stereotactic body radiation therapy (SBRT) use, outcomes, hospitalizations and costs compared to patients receiving chemotherapy among patients with metastatic non-small cell lung cancer (NSCLC).

Methods

Using the Surveillance, Epidemiology, and End Results (SEER)-Medicare database, we identified patients aged ≥66 with metastatic NSCLC treated with SBRT as first-line treatment between 2004 and 2014. Multivariable logistic regression identified covariates associated with SBRT. Overall survival (OS) between SBRT and chemotherapy was compared using the Kaplan-Meier estimator and Cox proportional hazards regression. To compare hospitalizations and associated costs, we matched patients treated with SBRT to those with comparable

SUBMITTER: Lester-Coll NH 

PROVIDER: S-EPMC9344414 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature